The European Commission has published a report outlining its priorities for the development of test methods for the identification of endocrine disrupting chemicals (EDCs). The report is based on an expert workshop held last summer that had the aim of:
- identifying gaps in the currently available test methods;
- identifying ways of filling those gaps; and
- prioritising further development and validation of test methods and approaches to testing.
About 70 experts attended from: EU institutions; member state authorities; universities, research centres, industry and NGOs. According to the report, attendees said the most important adverse outcomes for human health were:
- thyroid-related developmental neurotoxicity;
- metabolic dysfunction;
For more information, refer to the original document by clicking the source.